Board of Directors

Chung-Yu Wang, Honorary Ph.D., EMBA Diploma

Co-Founder, Chairman of the Board, Director and Interim Chief Executive Officer

Mr. Wang is our co-founder and has been Chairman of the Board and a director of the Company since its inception in April 2004. Mr. Wang acted as the Company’s Interim President from October 2008 to October 2015 and has been Interim Chief Executive Officer since May 2013. Mr. Wang brings to Pacgen broad and extensive experience in public company management, international business development and corporate restructure. Mr. Wang has been Independent Director of CTBC Bank Co., Ltd. and CTBC Financial Holding Co., Ltd. since 2008. Mr. Wang served as Chairman of Chinese International Economic Cooperation Association from 2008 to 2016 and Independent Director of Chunghwa Telecom Co., Ltd. from 2010 to 2016. Mr. Wang also previously served as Chairman of China Coal and Coke Investment Holding Limited from 2003 to 2007, Chairman of Tong Lung Metal Industry Co., Ltd. from 2002 to 2007, Chairman of China Steel Corporation from 1972 to 2001, as well as Chairman of the International Iron Institute and the Taiwan Steel and Iron Industries Association.

Mr. Wang was granted an Honorary Ph.D. degree in Chemical Engineering by Chung Yuan University, Taiwan. Mr. Wang received his Executive MBA Diploma from Harvard University and Bachelor degree in Chemical Engineering from Chung Yuan University, Taiwan.

Jeng-Horng Her, Ph.D.

Director

Dr. Her brings to Pacgen extensive experience in the life sciences sector. Dr. Her currently serves as the Chief Executive Officer of AP Biosciences, Inc. Dr. Her was Chief Executive Officer of ProtevoBio, Inc. which he founded in 2006. Prior to that, Dr. Her co-founded KaloBios Pharmaceuticals, Inc., a therapeutic antibody development company based in South San Francisco in California which has raised over US$76 million in private financing since its inception in 2001, where he was responsible for all clinical and regulatory affairs.

Dr. Her received his Ph.D. degree in Microbiology and Immunology from the University of Virginia, Virginia.

John Hsuan, Honorary Ph.D.

Director

Mr. Hsuan is an established and prominent business leader in Taiwan and brings to Pacgen a wealth of entrepreneur experience. Mr. Husan’s extensive background includes global operation management, international business development and venture capital experience. Mr. Hsuan has incubated and co-founded more than 20 public companies through out his career. He currently serves as Chairman of Maxima Ventures I, Inc., Meridigen Biotech Co., Ltd. and D-Link Corporation. He also currently serves as Vice Chairman Emeritus of United Microelectronics Corp. (“UMC”), a leading global semiconductor foundry traded on the New York Stock Exchange and the Taiwan Stock Exchange. During his tenure with UMC for over 20 years, Mr. Hsuan held key positions including Chief Executive Officer, Chairman and Vice Chairman. Mr. Hsuan was previously Chairman of Faraday Technology Corporation, NCTU Venture Capital Ltd. and NCTU Spring Venture Capital Co., Ltd.

Mr. Husan holds an Honorary Ph.D. degree and a Bachelor degree in Electronic Engineering from National Chiao Tung University, Taiwan. Mr. Hsuan is the recipient of numerous business achievement awards in Taiwan, and has been awarded 44 patents in the U.S. and 41 patents in Taiwan.

Fred Huang, MBA

Co-founder and Director

Mr. Huang is a co-founder of the Company and has been a director since August 2009. Mr. Huang was Senior Vice President and Chief Operating Officer of the Company from April 2006 to August 2009. Prior to his promotion, Mr. Huang was Chief Financial Officer of the Company from April 2004 to April 2006. Mr. Huang has extensive North American and Asian business experiences. He currently serves as Chief Operating Officer of AventaCell BioMedical Co., Ltd. He was Chief Executive Officer of Gworei Biomedical Technology Corp. from 2010 to 2014. Prior to joining Pacgen, Mr. Huang was Chief Financial Officer of Cytocan Biotechnology Inc. from 2002 to 2004. He was Senior Financial Advisor with Canadian Imperial Bank of Commerce Investor Services Inc. ("CIBC") where he built and managed a $150 million investment portfolio from 1997 to 2002. Prior to joining CIBC, Mr. Huang held various senior management positions with President Asian Enterprises Inc., Klockner Steel Corporation (Germany), and China Steel Corporation.

Mr. Huang received his MBA degree from the Marshall School of Business, University of Southern California and Bachelor of Engineering (Metallurgical) degree from National Taipei University of Technology, Taiwan.

Telvin Ju, Ph.D.

Lead Independent Director

Dr. Ju was appointed as Lead Independent Director of the Company in February 2014 and has been a director since October 2004. Dr. Ju is currently Chief Executive Officer of Associated Development Inc. and President of CMT Investment Co., Ltd., both of which are divisions of Chinese Maritime Transport Ltd. (“CMT”) listed on the Taiwan Stock Exchange. Dr. Ju has served as senior management of CMT since July 2003. He was previously President of Associated International Inc. and Senior Vice President of CMT. Dr. Ju’s key role in the CMT group of companies is to advise and consult for various venture capital and asset management companies on investments. Dr. Ju was previously a research associate at Johns Hopkins University in the Chemistry Department.

Dr. Ju received his Ph.D. degree in Chemistry and Bachelor of Science degree in Chemistry and Biology from the University of Miami, Florida.

Alan Savage

Director

Mr. Savage brings to Pacgen experience and expertise obtained over a long and successful career in the capital markets in North America and offshore, where he held various senior management positions in multiple publicly listed and privately held companies. Mr. Savage is founder and President of Southern Gold Resources Ltd., a successful investment and venture capital enterprise which he owns and operates since 1981. Mr. Savage is currently a director and a principal shareholder of Epicore Bionetworks Ltd., a publicly listed company. Among other accomplishments, Mr. Savage is founder of Imperial Metals Corporation (“IMC”), and was a director and President of IMC from 1978 to 1986. Under his administration as President of New Canamin Resources Ltd., Mr. Savage was credited with the discovery and commercialization of the Huckleberry copper deposit in British Columbia. Huckleberry continues to operate at 20,000 tonnes per day.

Christina Yip, MBA, CPA, CMA

Director, President and Chief Financial Officer

Ms. Yip was appointed as President of the Company in October 2015 and has been Chief Financial Officer since April 2006. Ms. Yip brings to Pacgen over 20 years of extensive experience in financial and strategic management. She has established a successful track record in completing corporate finance and business development transactions including initial public offering, public and private financing, financial restructuring, tax reorganization, cross-border merger and acquisition, licensing and various deal negotiation. Prior to joining Pacgen, Ms. Yip served as Vice President, Finance and Administration of Cardiome Pharma Corp., a TSX and NASDAQ listed pharmaceutical company. Ms. Yip also currently serves as President and Managing Director of KeenVision Consulting Inc. providing financial advisory and executive management services to various venture companies in the life sciences and mining sectors.

Ms. Yip is a Chartered Professional Accountant, Certified Management Accountant, and holds an Executive MBA degree from Simon Fraser University.